MediWound Ltd. - Likuiditas cepet MDWD

As reflected in the pakistan chart, the asset value of MediWound Ltd. (MDWD) currently stands at 2.18. MediWound Ltd. (MDWD) is striving for the global implementation of NexoBrid for the therapy of severe skin injuries, expanding its presence in hospitals. The business relies on alliances with burn centers and military structures for the distribution of scar treatment products. Production is outsourced to external plants, yet key patents remain in-house, eliminating the risks of contractor dependency.

To assess the fundamental stability of MediWound Ltd. (MDWD), investors must analyze the company's ability to immediately settle short-term obligations. This metric compares cash and accounts receivable against current liabilities, completely ignoring low-liquidity inventories. An acid-test liquidity analysis reveals risks of cash flow gaps and the efficiency of capital management. The stability of this indicator confirms the financial foundation for implementing energy-efficient ESG standards within biotechnological production.